Biopharmaceutical Stock Owners Make Big Gains in Assets

SEOUL, Jan. 29 (Korea Bizwire) — Stock values for stakeowners of biopharmaceutical companies nearly doubled over the past year, with Celltrion leading the pack, data showed Sunday. According to Chaebul.com, which tracks corporate records, 32 people each owned more than 100 billion won (US$93.76 million) worth of shares in biopharmaceutical firms as of Friday’s closing. [...]